Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAMPION PCI: Cangrelor vs Clopidogrel in PCI
NCT00305162Phase 3Terminated
- Sponsor
- The Medicines Company
- Start
- Apr 2006
- Primary completion
- May 2009
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of cangrelor in acute coronary syndrome (ACS), myocardial infarction (MI), sponsored by The Medicines Company. Started Apr 2006; status: terminated.
02
Drugs
cangrelor
03
Conditions
acute coronary syndrome (ACS)myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00305162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305162.